Carla McWilliams, MD

Appointed
2016

Education & Fellowships

Fellowship - Northwell Health
Infectious Disease
New Hyde Park, NY USA
2013

Residency - Lutheran Medical Center
Internal Medicine
Brooklyn, NY USA
2011

Medical Education - Medical University of the Americas
Nevis, St. Kitts,
2006

Additional Training

• Board Certified in Internal Medicine
• Board Certified in Infectious Disease
• HIV Specialist, American Academy of HIV Medicine

Professional Highlights

• Professional educational materials

  MCWILLIAMS C. and Giaccio, D. USMLE Step 2 & 3 In Your Pocket, Kaplan Publishing, New York, New, York © 2013 Fischer, C. USMLE Step Three-Master the Boards (Content and Peer Reviewer), Kaplan Publishing, New York, New, York © 2012 MCWILLIAMS C. and Giaccio, D. USMLE Step 3 White Coat Pocket Guide Pocket Guide, Kaplan Publishing, New York, New, York © 2010 MCWILLIAMS C. and multiple authors, USMLE Step Three Online Question Bank, Kaplan Medical Test Prep and Admissions, New York, New, York © 2009 MCWILLIAMS C. and multiple authors, USMLE Step Two Online Question Bank, Kaplan Medical Test Prep and Admissions, New York, New, York © 2008 Fischer, C. and Faselis, C., USMLE Step Two CK Lecture Notes, Internal Medicine (Content and Peer Reviewer), Kaplan Medical Test Prep and Admissions, New York, New, York © 2008 Cvetnic W., Pino E., Koerner C., and MCWILLIAMS C., USMLE Step Two CK Lecture Notes, Pediatrics, Kaplan Medical Test Prep and Admissions, New York, New, York © 2008 MCWILLIAMS C. and multiple authors, USMLE Step Two PowerPoint Presentations for DVD Lecture Series (Contributing Author and Editor), Kaplan Medical Test Prep and Admissions, New York, New, York © 2007

  Peer Reviewed Publications and Posters

  CARLA MCWILLIAMS MD, Susan Condon, Rebecca M. Schwartz, Christine C Ginocchio. Incidence of Extended Spectrum β Lactamase Producing Escherichia coli and Klebsiella pneumonia Isolates That Test Susceptible to Cephalosporins and Aztreonam by the Revised CLSI Breakpoints. Journal of Antimicrobial Agents and Chemotherapy. Doi:10.1128/JCM03613-13, Published April 30th, 2014 CARLA MCWILLIAMS MD, Kourosh Golestany, MD, Rohit Sharma, MD, Golali Nejati, MD, Anna Cyrus-Murden, MD, MPH and Dmitri Kirpichnikov, MD. Correlation of admitted nursing home residents’ hospital length of stay and vitamin D levels. Department of Internal Medicine, Lutheran Medical Center, Brooklyn, New York, USA (http://www.jchimp.net/index.php/jchimp/article/view/6313/html) Vol 1, No 3, October 2011 Oikonomou KG MD, MCWILLIAMS C, MD Moussa MM MD. Oerskovia Species Bacteremia in a Diabetic Patient. J Global Infectious Disease. 2018 April-June. PMID 29910574. Rojas E MD, Gillenwater S MD, Rivas A MD, Wulff L MD, Kaur J MD, Gonzalez M MD, De Armas Y MD, MCWILLIAMS C MD, Martinez F MD, Bejarano P MD, Hadah A MD. Incidental Pulmonary Cryptococcocus in an Asymptomatic Liver Transplant Patient. American Thoracic Society Meeting, 5/22/19, Dallas Texas  CARLA MCWILLIAMS MD, Orly Hadar MD, Amy Van MS. Factors Associated with Positive Follow Up Blood Cultures in Gram Negative Septicemia. 10/3/19. IDSA Annual Meeting, Washington DC Nicholas Brozzi, Jaime Hernandez-Montfort, Edward Noguera, CARLA MCWILLIAMS, Cedric Sheffield, Steven Minear, Jeffrey Jacobs, Viviana Navas, Mauricio Velez, Robert Cubeddu, Jose L Navia "Successful mobile extracorporeal member oxygenator for COVID-19 severe respiratory failure" Journal of Cardiac Surgery Case Reports, December 2020 Gilda Portalatin, Jodi Ann Chin, Brian Foster, Kevin Perry, CARLA MCWILLIAMS "Daptomycin Induced Acute Eosinophilic Pneumonia" Cureus Feb 2021 Suma Thomas, Divyang Patel, Barbara Bittel, Kathy Wolski, Qiuqing Wang, Anirudh Kumar, Zachary Il'Giovine, Reena Mehra, CARLA MCWILLIAMS, Steve Nissen, Miliand Desai "Effect of High Dose Zinc and Ascorbic Acid Supplementation vs. Usual Care on Symptom Length and Reduction Among Ambulatory Patients with SARS-Co-V-2 Infection" JAMA Open Network April 2021 Paul C Cremer, Prof Antonio Abbate, MD, Kristin Hudock MD, CARLA MCWILLIAMS MD, Jinesh Mehta MD, Prof Steven V. Chang et al "Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicenter, double-blind, randomised, placebo-controlled trial" The Lancet Rheumatology March 2021 Jesus Villa, Tejbir Pannu, CARLA MCWILLIAMS, Chandra Kizer, Raul Rosenthal, Carlos Higuera, Preetesh Patel"Results of Preoperative Screening for COVID-19 Correlate with the Incidence of Infection in the General Population-A Tertiary Care Experience" Journal of Hospital Practice March 2021

Awards & Honors

• The Jose M Muniz Best Teaching Faculty Award, Department of Internal Medicine, Cleveland Clinic Florida 2017-2018
• Clinician of the Year Award 2019, Women’s Professional Staff Association, Cleveland Clinic Florida
• Clinician of the Year Award 2020, Cleveland Clinic Florida Professional Staff Association

See publications for Carla McWilliams, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 2/17/2022, Dr. McWilliams has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.